Biocides

Antimicrobial Fabric: Global Markets to 2026 - Growing Demand for Athleisure Wear - ResearchAndMarkets.com

Retrieved on: 
Friday, July 16, 2021

The "Antimicrobial Fabric: Global Markets to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Antimicrobial Fabric: Global Markets to 2026" report has been added to ResearchAndMarkets.com's offering.
  • The global market for antimicrobial fabric should grow from $10.1 billion in 2021 to $11.8 billion by 2026, at a compound annual growth rate (CAGR) of 3.2% for the period of 2021-2026.
  • Metal and metal salts agents are in high demand in all applications due to their low toxicity and better efficacy.
  • In this report, the antimicrobial fabric market is segmented by fabric, antimicrobial agent and application.

Sterilization Services Market by Method, Type, Mode of Delivery, End-user and COVID-19 Impact - Global Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 15, 2021

The ethylene oxide (EtO) sterilization segment accounted for the largest share of the sterilization services market in 2020.

Key Points: 
  • The ethylene oxide (EtO) sterilization segment accounted for the largest share of the sterilization services market in 2020.
  • Based on type, the sterilization services market has been segmented into contract sterilization services and sterilization validation services.
  • Based on mode of delivery, the sterilization services market has been segmented into off-site sterilization services and on-site sterilization services.
  • In 2020, the off-site sterilization services segment accounted for a larger share of the sterilization services market.

Greek National Organization Of Medicines Approves First Antimicrobial Formula For Residual Surface Protection Against SARS-CoV-2 (COVID-19 Virus) For Up To 90 Days

Retrieved on: 
Wednesday, July 14, 2021

Greece has recognized BIOPROTECTTM RTU as inhibiting the growth of harmful bacteria and viruses, including SARS-CoV-2 (COVID virus), on surfaces for up to 90 days.

Key Points: 
  • Greece has recognized BIOPROTECTTM RTU as inhibiting the growth of harmful bacteria and viruses, including SARS-CoV-2 (COVID virus), on surfaces for up to 90 days.
  • We've delivered an effective antimicrobial surface protectant solution that supports our mission of continued research, innovation, and dedication on a global scale."
  • ViaClean Technologies LLC is a biotech company that develops, manufactures, and markets groundbreaking, innovative antimicrobial solutions using environmentally responsible manufacturing processes.
  • ViaClean Technologies' pioneering and proprietary technologies, products, and services provide disinfectants, antimicrobial protectants, and hand sanitizers for commercial and consumer use.

Qualigen Therapeutics, Inc. Announces Submission of Investigational New Drug (IND) Application for QN-165, for the Treatment of COVID-19

Retrieved on: 
Wednesday, July 14, 2021

QN-165, a DNA aptamer, is a broad-based antiviral drug candidate that has exhibited antiviral activity in multiple in vitro assays against different viruses.

Key Points: 
  • QN-165, a DNA aptamer, is a broad-based antiviral drug candidate that has exhibited antiviral activity in multiple in vitro assays against different viruses.
  • We are excited to have reached this important milestone of submitting our first IND application to the FDA on our most advanced therapeutics program.
  • Viruses such as SARS-CoV-2 exploit nucleolin to gain access to a cell and manipulate it for its own viral replication purposes.
  • STARS is a DNA/RNA-based treatment device candidate for removal from circulating blood of precisely targeted tumor-produced and viral compounds.

Greek National Organization of Medicines Approves First Antimicrobial Formula for Residual Surface Protection Against SARS-CoV-2 (COVID-19 Virus) for up to 90 Days

Retrieved on: 
Wednesday, July 14, 2021

Greece has recognized BIOPROTECTTM RTU as inhibiting the growth of harmful bacteria and viruses, including SARS-CoV-2 (COVID virus), on surfaces for up to 90 days.

Key Points: 
  • Greece has recognized BIOPROTECTTM RTU as inhibiting the growth of harmful bacteria and viruses, including SARS-CoV-2 (COVID virus), on surfaces for up to 90 days.
  • We've delivered an effective antimicrobial surface protectant solution that supports our mission of continued research, innovation, and dedication on a global scale."
  • ViaClean Technologies LLC is a biotech company that develops, manufactures, and markets groundbreaking, innovative antimicrobial solutions using environmentally responsible manufacturing processes.
  • ViaClean Technologies' pioneering and proprietary technologies, products, and services provide disinfectants, antimicrobial protectants, and hand sanitizers for commercial and consumer use.

Evrys Bio Awarded $34 Million from DOD to Develop a Single Drug Simultaneously Effective Against Multiple Lethal Viruses

Retrieved on: 
Tuesday, July 13, 2021

DOYLESTOWN, Pa., July 13, 2021 (GLOBE NEWSWIRE) -- Evrys Bio, a biotech company developing Next Gen Antivirals, was awarded a $34.3 million contract from the Department of Defense (DOD) to develop a drug, simultaneously effective against multiple high-risk viral agents.

Key Points: 
  • DOYLESTOWN, Pa., July 13, 2021 (GLOBE NEWSWIRE) -- Evrys Bio, a biotech company developing Next Gen Antivirals, was awarded a $34.3 million contract from the Department of Defense (DOD) to develop a drug, simultaneously effective against multiple high-risk viral agents.
  • The proposed drug intends to improve disease survival after exposure to one or more viruses from three families: alphaviruses, arenaviruses and filoviruses.
  • The DODs Defense Threat Reduction Agencys Chem Bio Technologies, Vaccines and Therapeutics Division executed an Other Transaction Authority (OTA) agreement with Evrys for this effort.
  • EVRYS stands for the Companys vision to ultimately address every virus, said Lillian Chiang, PhD, CEO, Evrys Bio.

FDA Approves Expanded Sterilization and Disinfectant Methods for the LUMINELLE® DTx System

Retrieved on: 
Monday, July 12, 2021

This expansion will allow the LUMINELLE DTx System to be more fully utilized in broader settings such as Hospital Systems and Outpatient Surgical Centers.

Key Points: 
  • This expansion will allow the LUMINELLE DTx System to be more fully utilized in broader settings such as Hospital Systems and Outpatient Surgical Centers.
  • The newly approved reprocessing methods include the Steris Revital-Ox RESERT HLD as a high-level disinfectant method and the Steris V-PRO Low Temperature Sterilization as a sterilization method for the LUMINELE DTx System.
  • Currently, Metricide OPA Plus high-level disinfectant and Anderson Scientific's Flexible Bag Ethylene Oxide sterilization are approved for the LUMINELLE DTx System.
  • The LUMINELLE DTx System is FDA cleared for both diagnostic and therapeutic hysteroscopy and cystoscopy.

Cleanfarms Names Regions for Unwanted, Old Ag Pesticides and Livestock/Equine Medications Collection this Fall

Retrieved on: 
Monday, July 12, 2021

When they use our program, farmers have peace of mind that Cleanfarms will dispose of the materials safely, said Cleanfarms Executive Director Barry Friesen.

Key Points: 
  • When they use our program, farmers have peace of mind that Cleanfarms will dispose of the materials safely, said Cleanfarms Executive Director Barry Friesen.
  • Since the collection and safe disposal of unwanted pesticides and old livestock/equine medication began, the program has safely disposed of 3.7 million kg of old pesticides and 47,800 kg of obsolete farm animal health medications.
  • Cleanfarms rotates the collection program so that events return to regions every three years, based on participant feedback.
  • In addition to the collection program for unwanted pesticides and old livestock/equine medications, Cleanfarms collects empty plastic agricultural pesticide and fertilizer containers, grain bags and twine for recycling.

Cleanfarms Names Regions for Unwanted, Old Ag Pesticides and Livestock/Equine Medications Collection this Fall

Retrieved on: 
Monday, July 12, 2021

When they use our program, farmers have peace of mind that Cleanfarms will dispose of the materials safely, said Cleanfarms Executive Director Barry Friesen.

Key Points: 
  • When they use our program, farmers have peace of mind that Cleanfarms will dispose of the materials safely, said Cleanfarms Executive Director Barry Friesen.
  • Since the collection and safe disposal of unwanted pesticides and old livestock/equine medication began, the program has safely disposed of 3.7 million kg of old pesticides and 47,800 kg of obsolete farm animal health medications.
  • Cleanfarms rotates the collection program so that events return to regions every three years, based on participant feedback.
  • In addition to the collection program for unwanted pesticides and old livestock/equine medications, Cleanfarms collects empty plastic agricultural pesticide and fertilizer containers, grain bags and twine for recycling.

COVID-19 Treatment Clinical Landscape Research Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 9, 2021

The "Disease Analysis: COVID-19 Treatment" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Disease Analysis: COVID-19 Treatment" report has been added to ResearchAndMarkets.com's offering.
  • The commercial outlook for COVID-19 therapeutics is expected to decline progressively throughout 2021 due to the phased implementation of global vaccination programs, which should substantially reduce both outpatient and hospital COVID-19 cases.
  • Veklury faces myriad threats from pipeline candidates, including antivirals, immunomodulatory agents, monoclonal antibodies, and hyperimmune globulin therapies.
  • The overall likelihood of approval of a Phase I antiviral asset is 12.9%, and the average probability a drug advances from Phase III is 68.5%.